Cargando…
Post-Transplant Diabetes Mellitus After Kidney Transplant in Hispanics and Caucasians Treated with Tacrolimus-Based Immunosuppression
BACKGROUND: Development of post-transplant diabetes mellitus after kidney transplant (PTDM) significantly increases kidney graft loss and mortality. Several risk factors for PTDM have been reported, including Hispanic ethnicity and the use of calcineurin inhibitors and corticosteroids. The incidence...
Autores principales: | Baron, Pedro W., Infante, Sergio, Peters, Regina, Tilahun, Jerusalem, Weissman, Jill, Delgado, Lauren, Kore, Arputharaj, Beeson, W. Lawrence, de Vera, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248042/ https://www.ncbi.nlm.nih.gov/pubmed/28533501 http://dx.doi.org/10.12659/AOT.903079 |
Ejemplares similares
-
Exploring the safety and efficacy of adding ketoconazole to tacrolimus in pediatric renal transplant immunosuppression
por: Méndez, Sindy, et al.
Publicado: (2020) -
Beta and Angiotensin Blockades Are Associated With Improved 10‐Year Survival in Renal Transplant Recipients
por: Aftab, Waqas, et al.
Publicado: (2013) -
Abstract 37: Whole Eye Allograft Transplantation And Immunosuppression: Survival Of The Transplanted Rodent Eye Using Tacrolimus Monotherapy
por: Chen, Wendy, et al.
Publicado: (2018) -
High Tacrolimus Intrapatient Variability and Subtherapeutic Immunosuppression are Associated With Adverse Kidney Transplant Outcomes
por: Mendoza Rojas, Aleixandra, et al.
Publicado: (2022) -
Post-transplant Diabetes Mellitus in Kidney Transplant Recipients in Sudan: A Comparison Between Tacrolimus and Cyclosporine-Based Immunosuppression
por: Yousif, Elamein, et al.
Publicado: (2022)